Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention

被引：2

作者：

Foo, Fiona ^{[1
]}

Oldroyd, Keith G. ^{[1
]}

机构：

[1] Jubilee Natl Hosp, W Scotland Reg Heart& Lung Ctr, Glasgow G81 4HX, Lanark, Scotland

来源：

BIOMARKERS IN MEDICINE | 2011年 / 5卷 / 01期

关键词：

acute coronary syndrome; antiplatelet therapy; aspirin resistance; clopidogrel resistance; percutaneous coronary intervention; platelet function testing; ACUTE MYOCARDIAL-INFARCTION; SIROLIMUS-ELUTING STENTS; PLATELET-FUNCTION TESTS; RECURRENT CARDIOVASCULAR EVENTS; THROMBIN-RECEPTOR ANTAGONIST; CHRONIC CLOPIDOGREL THERAPY; PRINC PLAVIX RESPONSE; LONG-TERM OUTCOMES; LOW-DOSE ASPIRIN; OF-CARE ANALYSIS;

D O I：

10.2217/BMM.11.2

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Dual antiplatelet therapy with aspirin and clopidogrel is recommended in all patients who have had an acute coronary syndrome or who undergo percutaneous coronary intervention to prevent further ischemic events. Resistance or reduced responsiveness to aspirin and/or clopidogrel has been associated with adverse cardiovascular outcomes, including stent thrombosis. There have been significant advances in this field, which aim to overcome antiplatelet resistance, including the development of new antiplatelet agents. The rationale for dual antiplatelet therapy, the impact of suboptimal efficacy and the potential ways of overcoming resistance or variability in response to antiplatelet agents will be reviewed in this article.

引用

页码：9 / 30

页数：22

共 149 条

[1] Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].

Airoldi, Flavio ;

Colombo, Antonio ;

Morici, Nuccia ;

Latib, Azeem ;

Cosgrave, John ;

Buellesfeld, Lutz ;

Bonizzoni, Erminio ;

Carlino, Mauro ;

Gerckens, Ulrich ;

Godino, Cosmo ;

Melzi, Gloria ;

Michev, Iassen ;

Montorfano, Matteo ;

Sangiorgi, Giuseppe Massimo ;

Qasim, Asif ;

Chieffo, Alaide ;

Briguori, Carlo ;

Grube, Eberhard .

CIRCULATION, 2007, 116 (07) :745-754

[2] Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis - A case-control study [J].

Ajzenberg, N ;

Aubry, P ;

Huisse, MG ;

Cachier, A ;

El Amara, W ;

Feldman, LJ ;

Himbert, D ;

Baruch, D ;

Guillin, MC ;

Steg, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1753-1756

[3] Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases [J].

Aleil, B ;

Ravanat, C ;

Cazenave, JP ;

Rochoux, G ;

Heitz, A ;

Gachet, C .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :85-92

[4] ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) [J].

Anderson, Jeffrey L ;

Adams, Cynthia D. ;

Antman, Elliott M. ;

Bridges, Charles R. ;

Califf, Robert M. ;

Casey, Donald E. ;

Chavey II, William E. ;

Fesmire, Francis M. ;

Hochman, Judith S. ;

Levin, Thomas N. ;

Lincoff, A. Michael ;

Peterson, Eric D. ;

Theroux, Pierre ;

Wenger, Nanette Kass ;

Wright, R. Scott .

CIRCULATION, 2007, 116 (07) :803-877

[5] Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment [J].

Angiolillo, DJ ;

Fernandez-Ortiz, A ;

Bernardo, E ;

Ramírez, C ;

Sabaté, M ;

Jimenez-Quevedo, P ;

Hernández, R ;

Moreno, R ;

Escaned, J ;

Alfonso, F ;

Bañuelos, C ;

Costa, MA ;

Bass, TA ;

Macaya, C .

DIABETES, 2005, 54 (08) :2430-2435

[6] A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study [J].

Angiolillo, Dominick J. ;

Capranzano, Piera ;

Goto, Shinya ;

Aslam, Mohammed ;

Desai, Bhaloo ;

Charlton, Ronald K. ;

Suzuki, Yoshie ;

Box, Lyndon C. ;

Shoemaker, Steven B. ;

Zenni, Martin M. ;

Guzman, Luis A. ;

Bass, Theodore A. .

EUROPEAN HEART JOURNAL, 2008, 29 (18) :2202-2211

[7] Functional effects of high Clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment [J].

Angiolillo, Dominick J. ;

Costa, Marco A. ;

Shoemaker, Steven B. ;

Desai, Bhaloo ;

Bernardo, Esther ;

Suzuki, Yoshie ;

Charlton, Ronald K. ;

Zenni, Martin M. ;

Guzman, Luis A. ;

Bass, Theodore A. .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (04) :440-445

[8] Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions -: Results of a randomized study [J].

Angiolillo, Dominick J. ;

Bernardo, Esther ;

Palazuelos, Jorge ;

Desai, Bhaloo ;

Weisberg, Ian ;

Alfonso, Fernando ;

Guzman, Luis A. ;

Hernandez-Antolin, Rosana ;

Zenni, Martin Z. ;

Macaya, Carlos ;

Fernandez-Ortiz, Antonio ;

Bass, Theodore A. .

THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) :161-168

[9] Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study [J].

Angiolillo, Dominick J. ;

Shoemaker, Steven B. ;

Desai, Bhaloo ;

Yuan, Hang ;

Charlton, Ronald K. ;

Bernardo, Esther ;

Zenni, Martin M. ;

Guzman, Luis A. ;

Bass, Theodore A. ;

Costa, Marco A. .

CIRCULATION, 2007, 115 (06) :708-716

[10] Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives [J].

Angiolillo, Dominick J. ;

Fernandez-Ortiz, Antonio ;

Bernardo, Esther ;

Alfonso, Fernando ;

Macaya, Carlos ;

Bass, Theodore A. ;

Costa, Marco A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) :1505-1516

← 1 2 3 4 5 6 7 8 9 10 →